Binance, the world’s largest cryptocurrency exchange by volume, recently announced a significant change in its structure. Following legal challenges in the United States, Binance is eager to open a new chapter by intensifying its investments in innovative technologies across various sectors. As part of this strategy, Binance Labs has rebranded itself as YZi Labs.
Latest Developments in Binance
The rebranding of Binance Labs reflects a strategic shift in focus. Now known as YZi Labs, the company aims to expedite investments in biotechnology. Recently, Jane He was appointed as General Partner to lead biotechnology investments and enhance its strategies in artificial intelligence and Web3.
Previously serving as an investor and COO at a Hong Kong-based hedge fund, He specializes in early-stage ventures in biotechnology and innovation-focused sectors. Her experience includes work in cancer therapies, metabolic treatments, genetic editing, and medical devices.
Holding an MBA from Stanford, Jane is well-positioned to contribute to the company’s long-term strategy. Integrating blockchain with AI, YZi Labs is poised to increasingly invest in innovative projects within the biotechnology domain.
Jane expressed her enthusiasm regarding her new role at such a pivotal time. While leading biotechnology investments, her focus also encompasses AI and Web3, emphasizing the goal of identifying and supporting groundbreaking innovations in these areas.
About YZi Labs
Operating across six continents, YZi Labs has invested in over 250 projects in more than 25 countries. With billions of dollars in assets, 44.55% of these projects are listed on the Binance exchange, yielding substantial profits for early investors.
Binance’s investment arm has gained significant credibility with altcoins, achieving remarkable returns such as 354x for TIA and 118x for INJ Coin. Among its investments are cryptocurrencies like BEAM, CRV, BTT, CHZ, FTT, and more.
